Skip to content
healthcare.dev

Cladribine

NDC 62049-286, Cladribine, tablet, from Genvion Corporation.

Product NDC
62049-286
Status
Listed
Labeler
Genvion Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218425
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62049-286 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLADRIBINE10 mg/1

Pharmacologic classes

Purine Antimetabolite [EPC]

Package NDCNDC-11Package
62049-286-04620490286044 TABLET in 1 CARTON (62049-286-04)
62049-286-05620490286055 TABLET in 1 CARTON (62049-286-05)
62049-286-06620490286066 TABLET in 1 CARTON (62049-286-06)
62049-286-07620490286077 TABLET in 1 CARTON (62049-286-07)
62049-286-08620490286088 TABLET in 1 CARTON (62049-286-08)
62049-286-09620490286099 TABLET in 1 CARTON (62049-286-09)
62049-286-106204902861010 TABLET in 1 CARTON (62049-286-10)

Linked data

RxNorm, label and prices

Use it

Look up 62049-286 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62049-286 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62049-286. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.